Net loss of Oxygenta Pharmaceutical reported to Rs 0.91 crore in the quarter ended March 2022 as against net profit of Rs 0.81 crore during the previous quarter ended March 2021. Sales declined 36.16% to Rs 7.08 crore in the quarter ended March 2022 as against Rs 11.09 crore during the previous quarter ended March 2021.
For the full year,net loss reported to Rs 0.61 crore in the year ended March 2022 as against net profit of Rs 2.93 crore during the previous year ended March 2021. Sales rose 16.32% to Rs 60.52 crore in the year ended March 2022 as against Rs 52.03 crore during the previous year ended March 2021.
Powered by Capital Market - Live News